Drawing for EMD SERONO

USPTO serial 88220392

EMD SERONO

Reviewed by CopyMark Law Group

Reg. 6285603Status 700Renewal
Filing date
Status date
Registration date
Mar 9, 2021
Examiner
SCLEIDOROVICH, JOANNA YAEL
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EMD SERONO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,793*

Plus Government fees of $2,275

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William C. Wright

William C. Wright EPSTEIN DRANGEL LLP60 EAST 42ND STREET, SUITE 2520NEW YORK, NY 10165UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of diseases and disorders of neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology; prefilled syringes containing choriogonadotropin alfa, prefilled syringes containing follitropin alfa, prefilled syringes containing interferon beta-1a, prefilled syringes containing cetrorelixACTIVEOct 31, 2007
009Downloadable software in the nature of a mobile application that enables users to access healthcare informationACTIVENov 26, 2014
010Medical apparatus, instruments and equipment, namely, incubators and parts and fittings specially designed therefore used to support development of human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes for in vitro fertilization or treatment of infertility and other disorders relating to fertility and human reproduction; injection devices for pharmaceuticalsACTIVEOct 31, 2007
016Printed instructional and teaching material in the field of healthcareACTIVE
035Conducting business conferences in the healthcare areaACTIVEApr 25, 2018
041Providing training about the administration of drugs; conducting educational conferences in the healthcare areaACTIVEMay 19, 2012
044Providing medical information, consultancy and advisory servicesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 9, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 9, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 22, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 22, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 2, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 19, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 17, 2020XAECEXAMINER'S AMENDMENT ENTERED
Nov 17, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 17, 2020GNEAEXAMINERS AMENDMENT E-MAILED
Nov 17, 2020CNEAEXAMINERS AMENDMENT -WRITTEN
Oct 28, 2020XAECEXAMINER'S AMENDMENT ENTERED
Oct 28, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 28, 2020GNEAEXAMINERS AMENDMENT E-MAILED
Oct 28, 2020CNEAEXAMINERS AMENDMENT -WRITTEN
Oct 19, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Oct 19, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 19, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 23, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 23, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 23, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 9, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Apr 9, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 10, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 10, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 10, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 1, 2019DOCKASSIGNED TO EXAMINER
Aug 20, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 20, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 20, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 20, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 20, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 18, 2019DOCKASSIGNED TO EXAMINER
Dec 29, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 10, 2018NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance